Critical Mass Technologies has filed a notice of an exempt offering of securities to raise $7,120,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Critical Mass Technologies is raising up to $7,120,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Franklin Fritts played a key role in securing the recent investment.
About Critical Mass Technologies
SIDIS Health is now Boost! SIDIS Health Enterprise Clinical Operations Management is a native cloud-based SaaS 2.0 platform that empowers autism service companies to increase revenue and cash flows, cut costs and enhance outcomes. Rapid growth is enabled using enterprise process automation, workflow management and predictive analytics supported by artificial intelligence for complete clinical and operational integration. Be armed with the detailed outcome data required to develop nimble and sophisticated treatment strategies, negotiate better reimbursement rates and be ready for value-based payer contracts, all with a lean support staff. Track patient treatment progress with AI to compare patient types and identify infinite variables potentially affecting skill acquisition and identify what supervisors should pay close attention to for better outcomes. The standardized clinical data collected allows SIDIS AI to predict likely changes in skill acquisition rates based on care plan adaptations and provides more data to payers when requesting new authorizations. Corporate functions are provided with a real-time offline replicated database containing all collected transactional and operational data with open APIs to facilitate integration with internal or 3rd party BI tools, providing the ultimate visibility into the business without the need for custom integrations.
To learn more about Critical Mass Technologies, visit http://cmtapps.com/
Contact:
Franklin Fritts, Chief Executive Officer
415-517-6981
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.